AEON Biopharma Inc (AMEX:AEON) has a beta value of 0.27 and has seen 73.56 million shares traded in the last trading session. The company, currently valued at $1.02M, closed the last trade at $0.92 per share which meant it gained $0.26 on the day or 39.37% during that session. The AEON stock price is -134273.91% off its 52-week high price of $1236.24 and 56.52% above the 52-week low of $0.40.

The consensus among analysts is that AEON Biopharma Inc (AEON) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is 0.

AEON Biopharma Inc (AMEX:AEON) trade information

Sporting 39.37% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the AEON stock price touched $0.92 or saw a rise of 31.34%. Year-to-date, AEON Biopharma Inc shares have moved -97.63%, while the 5-day performance has seen it change 50.82%. Over the past 30 days, the shares of AEON Biopharma Inc (AMEX:AEON) have changed -89.40%.

AEON Biopharma Inc (AEON) estimates and forecasts

The company’s shares have lost -98.46% over the past 6 months.

AEON Dividends

AEON Biopharma Inc is expected to release its next earnings report in April this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Dec 31, 2024 , the former fund manager holds about 0.01% shares in the company for having 5.76 shares of worth $5301.0 while later fund manager owns 4.46 shares of worth $4100.0 as of Dec 31, 2024 , which makes it owner of about 0.01% of company’s outstanding stock.